Impact of Chronic and Acute Inflammation On Extra - and Intracellular Iron Homeostasis (Ross, 2017)
Impact of Chronic and Acute Inflammation On Extra - and Intracellular Iron Homeostasis (Ross, 2017)
Impact of Chronic and Acute Inflammation On Extra - and Intracellular Iron Homeostasis (Ross, 2017)
Am J Clin Nutr doi: https://doi.org/10.3945/ajcn.117.155838. Printed in USA. Ó 2017 American Society for Nutrition 1S of 7S
Iron that is not exported from the enterocytes can be expected to response generally begins locally and represents a highly evo-
be eliminated in sloughed cells (7). lutionarily conserved program of reactions related to innate
Other cells involved in iron homeostasis include tissue-resident immunity, which are relatively “hard wired” (i.e., modifiable but
macrophages (9) in the splenic red pulp and liver, which together not preventable). The acute response to infection and in-
comprise most of the reticuloendothelial system. Approximately flammation is closely related to immune defense, wound heal-
80% of liver-resident macrophages (Kupffer cells) line the hepatic ing, and tissue repair. Key features are the recruitment of white
venous sinusoids (10). Macrophages are crucial to the recycling of blood cells to the site of injury, through chemotactic and other
iron obtained from catabolism of spent red blood cells (RBCs), and mechanisms, and release of proinflammatory cytokines and
recycling is crucial to maintain a normal rate of RBC formation, chemokines, among which the TNF, IL-1, IL-6, and interferon
and thus for the prevention of anemia (9). Macrophages also store (IFN) families of proteins are predominant or most studied.
excess iron—for example, in situations of unrestrained iron ab- These proteins function as signals that initiate changes in me-
sorption from the diet, as in hereditary hemochromatosis (11). tabolism (19), which include the hepatic acute phase response
Moreover, tissue macrophages are, as will be noted later, also (APR). The APR, as its name implies, is a very rapid response
reservoirs for several intracellular pathogens and, furthermore, initiated by the insult and, optimally, sufficiently strong to deal
intimately involved in the innate immune response through the with the injury or infection, and then to be resolved back to
production of inflammatory factors. Hematopoietic cells in “baseline” homeostatic conditions. Although chronic inflam-
splenic and bone marrow use iron but may be inadequately sup- mation may begin locally, it is characterized by persistence over
plied in states of inflammation, leading to the anemia of in- time, dissemination, and failure to become completely resolved
flammation or anemia of chronic disease (12, 13). Finally, in or quelled, and is thus described as chronic, which implies a
pregnancy, the syncytiotrophoblast cells of the placenta, which survivable, long-term state that is sometimes referred to as “low
interface between the maternal and fetal circulations, function in grade” or mild inflammation.
iron homeostasis and fetal development by transferring iron de- The classical medical description of inflammation includes the
rived from maternal transferrin vectorially across the cell, which cardinal signs: pain, heat, redness, and swelling (i.e., dolor,
is released on the fetal side by a similar mechanism as occurs in caldor, rubor, turgor). The term “inflammation” as it is often
enterocytes involving FPN; however, in this situation, the ex- meant or inferred in relation to chronic diseases is harder to
ported iron becomes bound after oxidation to ferric iron to fetal define, because the origins of the condition itself are less clear.
transferrin. Maternal-to-fetal iron transfer is greatest in the third In fact, side-by-side comparisons between models of acute and
trimester of pregnancy, concomitant with the greatest rate of fetal chronic inflammation are scarce, and the use of the same term,
growth (14). inflammation, for both of them may mask differences yet to be
appreciated. Thus, although it seems safe to say that their gen-
eral features are similar, more research is needed to compare and
PROTEINS INVOLVED IN IRON HOMEOSTASIS elucidate them.
Free iron is toxic due to its participation in un- or poorly Chronic inflammation may result, instead of from acute injury,
regulated cellular and extracellular redox reactions (15), in- from metabolic disturbances, such as long-term tissue damage
cluding the well-known Fenton (Haber-Weiss) reaction in which such as caused by hypoxia, cell death, cellular necrosis, or
hydrogen peroxide and ferrous salts generate reactive species autophagy, arthritis, and other autoimmune disorders, or from
(free radicals) capable of oxidizing a wide variety of organic other nonacute injuries that also result in the recruitment of
substrates (16). Thus, biological mechanisms to bind and se- phagocytic and immune cells and in the production of proin-
quester iron are essential for controlling oxidant production and, flammatory cytokines. Conditions that have now become com-
hence, natural and induced oxidative damage. Nonheme iron is mon in the general population, such as obesity, are linked to
sequestered and transported in plasma by transferrin, which increased inflammation (20), which may be chronic and “low
possesses 2 high-affinity binding sites for 1 atom each of ferric grade” compared with the inflammation of acute infection;
iron. Heme iron, in addition to being contained within RBCs in nonetheless, the body’s pool of metabolically active adipose
hemoglobin, is bound extracellularly by the plasma protein tissue is large, and the inflammation-related cytokines and adi-
haptoglobin, whereas “free” heme is bound intracellularly to pokines produced therein are in intimate contact with other
hemopexin. These proteins function to limit the concentration of tissues through endocrine and paracrine interactions (21).
free inorganic iron and heme-bound iron within the extracellular
space, within cells, or both. Heme has been described as “a
double-edged sword” (17). In moderate quantities and bound to IMPORTANCE OF THE LIVER IN THE APR
protein, it is essential; in large amounts and free, it can become The APR, described .8 decades ago by Tillet and Francis
toxic by mediating oxidative stress and inflammation. Heme (see reference 10), is a highly conserved process found in all
toxicity underlies much of the pathology of sepsis and several mammals (19, 22–25). When infectious agents or their invoked
hemolytic disorders (18). cytokines enter the systemic circulation (sepsis or sterile in-
flammation with an elevation of proinflammatory cytokines), the
liver becomes a central organ of the inflammatory APR, which
ACUTE AND CHRONIC INFLAMMATION AND ITS IM- can be attributed to the following several features of the liver:
PACT ON IRON TRAFFICKING
1) Its anatomical location between the gut and other viscera.
Acute inflammation is part of the body’s natural response to
infection or injury and can rightly be considered an adaptive 2) Its dual venous blood supply, including the portal vein
response, as long as it remains within healthy limits. The through which the liver obtains intestinally derived
INFLAMMATION AND IRON HOMEOSTASIS 3S of 7S
materials, including microbes that have breached the in-
testinal epithelial barrier, immune cells educated in the
environment of the intestine (including and differing in
the lamina propria, intraepithelial lymphocyte compart-
ment, and specialized gut-associated lymphoid tissue)
(26), and a host of nutritional and other factors including
water-soluble nutrients, food-borne and absorbed toxins,
and cytokines produced in the intestine. Of note, the in-
testine is the body’s largest reservoir of immune cells (27),
including tolerogenic T lymphocytes, and others with in-
flammatory potential (26, 28). Interestingly, the composi-
tion of these cells differs in neonatal and adult life, with
few epithelial T cells in neonates (29). Nevertheless, at all
ages, the portal vein connects a major component of the
body’s innate and adaptive immune system (intestine,
spleen, and pancreas) with the liver (30).
3) The proximity of the apical surface of hepatocytes to the
venous sinusoids, separated only by loose, fenestrated en- FIGURE 1 Schematic of pathway from initial insult to the induction of
dothelial cells, such that these cells readily filter and take the AP response. See Kilicarslan et al. (24) and Trautwein et al. (31) for
up blood-borne materials. reviews of AP proteins. AGP, a1-acid glycoprotein; AP, acute phase; CRP,
C-reactive protein; IFN, interferon.
4) The intrinsic functions of the hepatocytes in central energy
metabolism, including glucose utilization and fatty acid the chaperone proteins haptoglobin and hemopexin, and the
transport. Thus, the utilization of all 3 major fuel sources intracellular iron chelator ferritin, which is also present in small
becomes altered during the APR, which can be considered amounts in plasma, all of which are induced in the APR (24).
a means to redistribute building blocks for tissue repair at Although few reviews of AP proteins have, until recently, listed a
sites of injury, at the (temporary) expense of normal he- sixth factor, hepcidin, it should now be considered an important
patic metabolism, in ways that provide an advantage to AP protein with regard to iron homeostasis (10). As discussed
host survival. further below, the APR affects the distribution of iron to cells
5) Hepatic synthesis of most of the plasma proteins. throughout the body and has significant implications for the
availability of iron to the host and to microbes in the case of
It is this latter function, specifically protein synthesis, that most infectious diseases.
research on the APR and acute phase (AP) proteins has addressed.
Human AP proteins, which number .180, include proteins of
the complement system, coagulation factors, antiproteases, REGULATION OF THE SYNTHESIS OF HEPATIC AP
transport proteins, and inflammatory response proteins (19). PROTEINS
Most of the AP proteins are induced during inflammation and It has become traditional to categorize AP proteins as either
many of them exert crucial effector functions—for example, in class I AP genes, exemplified by CRP, haptoglobin, SAA,
the regulation of blood clotting and as opsonins (24). The best- complement C3, hemopexin, haptoglobin, and AGP (10, 31),
known biomarker of inflammation, C-reactive protein (CRP), which are mainly regulated by IL-1 or by combinations of IL-1
named for its role in reacting to the C-polysaccharide component plus IL-6 or IL-1, IL-6, and glucocorticoids, and class II genes,
of Streptococcus pneumoniae, is an opsonic protein. Several exemplified by a2-macroglobulin, a1-antichymotrypsin, a1-
major AP proteins, considered to be markers of inflammation, antitrypsin, and fibrinogen, for which IL-6 and glucocorticoids
are noted in Figure 1. In humans, CRP and serum amyloid are the major inducers (31). However, current studies have
protein (SAA) are the most prominent responding proteins, with shown that the situation is likely more complex, involving dif-
increases of #100-fold during inflammation. In the rat, a2- ferential regulation by multiple factors. IL-1 and IL-6 still
macroglobulin and al-acid glycoprotein (AGP) are most prom- function as lead regulators, but the APR is further shaped by
inent (31). Although each AP protein exhibits changes in its hormones and other regulatory factors in a manner determined
concentration in plasma after the induction of the APR, the by different inflammatory stimuli (10). The IL-1 family
magnitude and duration of response differ among them; CRP proteins (IL-1b being the most studied) may be the most com-
and SAA proteins are induced very rapidly and to very high con- plex, with both inductive and inhibitory activity (10). IL-1 gen-
centrations after exposure to an inflammatory stimulus, whereas erally signals via pathways that lead to the induction of the
haptoglobin and fibrogen, for example, increase less rapidly and nuclear transcription factor kB, a major regulator of proin-
dramatically (23). Albumin, a major regulator of oncotic pres- flammatory signaling (31). IL-6, originally identified as a B cell
sure, and transferrin as well as several other nutrient transport differentiation factor, is a multifunctional cytokine whose de-
proteins are negative AP proteins (22, 23, 31) that are reduced regulation is implicated in several disease processes, including
in concentration. autoimmune diseases and chronic inflammatory proliferative
At least 5 AP proteins are directly involved in iron trafficking diseases (32). IL-6 signals through its cell surface IL-6–binding
(Figure 1): transferrin, the transport/redox protein ceruloplasmin, protein, IL-6R, coupled to the accessory signaling protein
4S of 7S ROSS
glycoprotein 130; these signals are transduced from the cell to oxygen and oxidant and antioxidant signaling (39), as well as
surface intracellularly through several additional protein factors genetic factors (34, 40). As listed in Table 1, numerous factors
including the protein signal transducer and activator of tran- and physiologic states result in the increased or decreased ex-
scription (STAT) 3 (33). pression of HAMP and concentrations of hepcidin in plasma.
As reviewed by Bode et al. (10), signals from infection, injury, Therefore, hepcidin concentrations are very sensitively regu-
inflammation, or neoplasms induce a response by macrophages lated, and it can be anticipated that iron efflux from cells is
and monocytes and other inflammatory cells that results in the regulated in parallel. As the “master regulator” of iron metab-
release of mediators. These factors then, in liver, influence olism, the hepcidin-ferroportin axis serves to control iron ab-
Kupffer cells and sinusoidal endothelial cells to produce addi- sorption (enterocytes), iron in the extracellular space (via
tional cytokines (IL-1, IL-6, TNF) that are received by receptors sequestration in macrophages), and transplacental iron transport,
on the adjacent hepatocytes and regulate the APR. Examples via regulation of FPN on syncytiotrophoblasts (4, 5, 10, 14).
based on model studies in isolated murine hepatocytes show that
IL-1b can either suppress the induction of protein synthesis by
IL-6, with little to no induction by IL-1b alone as in the case of THE APR AS A MEANS TO DEPRIVE MICROBES OF
g-fibrinogen mRNA expression; or as shown for hepcidin NUTRIENTS
mRNA, IL-1b can strongly synergize with IL-6, whereas neither Excellent reviews (4, 5) have addressed the fundamental
cytokine by itself is a strong inducer [Figure 1B, C in (10)]. competition for iron between the host (human or animal) and
These studies represent the potential and complexity of cytokine infectious agents, many if not most of which require iron for
regulation of the APR. However, further studies in primary growth, and therefore iron availability constitutes a virulence
human hepatocytes, especially those that are representative of factor. In the host-microbe competition for this essential nutrient,
different metabolic and physiologic states, including trimesters microbes have evolved sophisticated strategies to outcompete the
of pregnancy and age (infancy to adult), would be very desirable host, including the production of siderophores with high affinity
for a better understanding of the impact of inflammatory me- for iron. Soares and Wiess (4) comment on host mechanisms that
diators, in addition to IL-1b and IL-6, on the hepatic APR and are cytotoxic to the offending microbes, but also, “However,
AP protein production under a range of conditions. there are also resistance mechanisms..that prevent pathogens
With regard to the differences in response to IL-1b and IL-6 from accessing metabolites and/or nutrients that are essential for
reported by Bode et al. (10), several potential mechanisms were their survival and/or proliferation,” a defense strategy they refer
suggested, including cross-regulation of IL-1b and IL-6 soon to as “nutritional immunity,” which comprises ways that the host
after cell surface signaling, intracellular induction or suppres- attempts to limit iron availability to the infectious bacteria.
sion involving specific protein factors, competition at the level These investigators present the general principle that “Adaptive
of transcription factor binding to DNA elements, and seques- responses supplying Fe to microbes increase, in most cases, their
tration of transcription factors on cryptic or unproductive DNA pathogenicity, while those withholding Fe from microbes limit
sites, any or all of which could affect the transcriptional regu- their virulence” (4).
lation (the main form of regulation) of the production of AP What host responses help in compensation? This question is
proteins (10). To move from bench to bedside, or public health, interesting because the appropriate response depends on whether
these mechanisms, too, will be important to elucidate in cells the pathogen resides intracellularly [examples such as Candida,
that represent various physiologic conditions. Chlamydia, Legionella, Salmonella, and Mycobacterium species
(4)] or extracellularly (examples such as blood-phase malaria).
The issue is important because the location of the pathogen may
HEPCIDIN AS AN AP PROTEIN IN THE RESPONSE TO affect the outcome to host supplementation with iron. With re-
INFLAMMATION gard to extracellular iron and extracellular pathogens, clinical
Liver is the major site of hepcidin synthesis, as indicated by and epidemiologic studies have shown that host iron overload is
higher concentrations of hepcidin antimicrobrial peptide associated with poor clinical outcomes in diseases such as
(HAMP) mRNA in hepatocytes, compared with other organs and AIDS, malaria, and tuberculosis (4) and that dietary iron sup-
cells; however, it is interesting that HAMP mRNA is also de- plementation (assumed to increase extracellular iron initially)
tectable, albeit at lower concentrations, in other tissues and cell can exacerbate overall mortality rate in areas of endemic in-
types and may be synthesized in cells that also express FPN fectious diseases (5). Unbound iron in the host is a source of iron
[reviewed in (34)]. As noted above, HAMP is regulated mainly to extracellular pathogens; moreover, extra- and intracellular
transcriptionally. The hepcidin protein is first translated as an unbound iron can generate toxic free radicals and potentially
84-amino acid preprohormone, cleaved co-translationally to a result in tissue damage. Therefore, counteracting mechanisms to
60-amino acid prohormone, and secreted as a 25-amino acid limit the concentration of unbound iron are extremely important.
hormone. A shortened form, hepcidin-20 (Hep-20), which lacks These include the chaperoning of iron by transferrin in plasma
the first 5 N-terminal amino acids, appears to have antimicrobial [which also targets iron via the interaction of transferrin with the
activity but lacks iron regulatory activity (34, 35). Hepcidin was plasma membrane-associated transferrin receptor (TfR), CD71];
initially called liver-expressed antimicrobial protein (LEAP) 1 lactoferrin, which is present in milk and other secretions (41);
on the basis of its antimicrobial function (36). ferritin as an intracellular chaperone and high-capacity seques-
A variety of factors may contribute to the regulation of HAMP trant of iron; hemoglobin, as the functionally important carrier
expression, mostly shown in vitro, including a suppressive effect of most iron; haptoglobin, as the chaperone of unbound hemo-
of hepatocyte nuclear factor (HNF) 4 (37), induction by factors globin [such as that released from RBCs at sites of injury and
related to endoplasmic reticulum stress (38), and factors related hemolysis (9, 18)]; and hemopexin, an intracellular chaperone
INFLAMMATION AND IRON HOMEOSTASIS 5S of 7S
TABLE 1
Hepcidin characteristics and regulation1
Characteristics Site of synthesis or action Functions and regulation
Peptide hormone (25-amino acid); Multiple (4); presumably where “Innate nutritional response” factor;
short form, Hep-20 bacteria reside (35) antimicrobial activity (greater for Hep-20?)
“Master regulator” of iron metabolism Binds and assists further degradation of Acts in conjunction with FPN protein to
FPN present on the basolateral limit the efflux/export of iron from
membrane of enterocytes (7, 8); FPN-expressing cells
liver and splenic macrophages;
placental syncytiotrophoblast cells (14)
Synthesis is mainly regulated Liver parenchymal cells; others? Induced by hyperferremia, cytokines (IL-1, IL-6, and IL-22;
at the level of transcription (mRNA detected extrahepatic tissues (34) type I interferons), LPS/toll-like receptor 4 signaling,
intracellular innate inflammatory responses, and
repressed by hypoferremia/iron deficiency, anemia, tissue
hypoxia (increased erythropoietic drive) (13, 34)2
1
FPN, ferroportin; Hep-20, hepcidin-20; mRNA, messenger RNA.
2
Underlined text indicates factors related to inflammation.
for free heme, which interacts with the enzyme heme oxygenase 1 damaged RBCs, can induce phagocytosis and the release of
(HO-1), to catabolize free heme (17). It is also relevant that heme, which may scavenge nitrous oxide and cause local
transferrin is normally only partially saturated with iron, providing a vasoconstriction. Released oxidized heme, as a ligand for
reserve of “iron binding capacity” to take up free iron when it is in G-protein-coupled receptors on polymorphonuclear leukocytes,
excess. may stimulate the release of reactive oxygen species and cause
The ability of macrophages to take up and store iron is well more damage; and released oxidized heme may serve as a ligand
known (9), and Kupffer cells have an especially high capacity for for Toll-like receptors on endothelial cells, causing endothelial
the storage of excess iron (42). Schematically (Figure 2), inflammation. Scavenging of heme iron and oxidized heme are
macrophage iron metabolism should be regulated differentially important for reducing their presence in the extracellular fluid,
in response to the presence of extracellular pathogens (Figure and HO-1 is an important intracellular control mechanism for the
2A) and intracellular pathogens (Figure 2B), the common degradation of free heme (43). Moreover, one of its reaction
products, carbon monoxide, is cytoprotective (43, 44).
“theme” being to reduce the co-compartmentalization of the
pathogen or pathogens and available iron. Several potential
mechanisms are listed in Figure 2. PREGNANCY AND INFANCY
The microvasculature is also sensitive to iron status and the Information on the mechanisms of the regulation of iron
products of RBC damage [reviewed in (4)]. Free heme is a danger transport and metabolism, as affected by inflammation, in
signal; oxidized heme released from infected RBCs has multiple pregnancy and in newborns is extremely limited. With respect to
effects on tissue microvasculature and tissue damage, including CRP concentrations as a general indicator of inflammation,
FIGURE 2 Schematic of differential adaptive responses to segregate iron from microbes in the situation with extracellular infectious agents in which
sequestration of iron intracellularly generally favors the host’s response (A) and with intracellular infectious agents in which removal of iron from the cell
generally favors the host’s response to infection (B). (See references 4 and 5 for additional information). FPN, ferroportin.
6S of 7S ROSS
systemic CRP concentrations in pregnancy have been found to needed. Because hepcidin is now well established as a major
be within the range that is normal for healthy, nonpregnant regulator, additional studies on the meaning of HAMP expression
individuals (45), or categorized as “normal/insignificant” in extrahepatic tissues would also be timely.
(,1 mg/dL) (24). Yet, whether more local tissue differences A key question is to what extent small differences in in-
exist is not well known. Studies of implantation have shown flammatory status (and how these should be assessed) affect
that a controlled, local immune response, characterized by the hepcidin concentrations and to what extent these differences
presence of IL-6, IL-8, TNF, and T-helper 1 cells, is essential for actually result in tangible changes in iron transport, intracellular
implantation, which, if blocked, results in implantation fail- iron storage and metabolism, and functional outcomes. Over-
ure (46). Similarly, parturition requires a local uterine or sys- laying all of this is the effect of infection, the differences in
temic inflammatory response (47). Thus, understanding the response to extracellular and intracellular microbes, and their
impact of “inflammation” on iron status in pregnancy will re- impact on health and survival.
quire studies that specifically consider local and systemic in-
The author was solely responsible for the manuscript. The author had no
flammation and that integrate knowledge of iron-regulatory conflict of interest related to the study.
pathways with acceptable biomarkers of inflammation. Hepcidin
concentrations decrease and become very low in the course of
pregnancy but are higher in pregnancy with inflammation (14).
Concentrations normally increase around delivery (48). Key REFERENCES
1. Thurnham DI. Interactions between nutrition and immune function:
questions (14) are to what extent the variation in hepcidin using inflammation biomarkers to interpret micronutrient status. Proc
concentrations is actually regulatory for iron status and how do Nutr Soc 2014;73:1–8.
we interpret the biological significance of these differences? 2. Raiten DJ, Sakr Ashour FA, Ross AC, Meydani SN, Dawson HD,
Finally, syncytiotrophoblast cells take up iron from maternal Stephensen CB, Brabin BJ, Suchdev PS, van Ommen B. Inflammation
and Nutritional Science for Programs/Policies and Interpretation of
holo-transferrin via apical TfR, have some capacity to store iron, Research Evidence (INSPIRE). J Nutr 2015;145(Suppl):1039S–108S.
and release ferrous iron to the fetal circulation through the 3. Anderson GJ, Wang F. Essential but toxic: controlling the flux of iron
mediation of FPN on the fetal side for oxidation and removal by in the body. Clin Exp Pharmacol Physiol 2012;39:719–24.
fetal transferrin. The placenta also expresses HO-1. Both placental 4. Soares MP, Wiess G. The Iron age of host–microbe interactions.
EMBO Rep 2015;16:1482–500.
HO-1 expression and exhaled carbon monoxide concentrations were 5. Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis.
reported to be lower in women with severe pre-eclampsia, which is Science 2012;338:768–72.
consistent with the idea of a pathogenic role for low HO-1, whereas 6. Gasche C, Lomer MCE, Cavill I, Weiss G. Iron, anaemia, and in-
an in vitro experiment suggested that the induction of HO-1 and flammatory bowel diseases. Gut 2004;53:1190–7.
7. Ganz T. Cellular iron: ferroportin is the only way out. Cell Metab 2005;
carbon monoxide production reduced the expression of anti- 1:155–7.
angiogenic factors (49). 8. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S,
With regard to infants, recent results by Hedengran et al. (48) Andrews NC. The iron exporter ferroportin/Slc40a1 is essential for iron
suggest a spike, with considerable variability, in neonatal blood homeostasis. Cell Metab 2005;1:191–200.
9. Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macro-
hepcidin concentrations 1–2 d after birth. Another study in phages. Nat Immunol 2013;14:986–95.
healthy full-term infants born in Sweden and therefore pre- 10. Bode JG, Albrecht U, Håussinger D, Heinrich PC, Schaper F. Hepatic
sumably from well-nourished iron-replete mothers showed a acute phase proteins—regulation by IL-6- and IL-1-type cytokines
sharp increase in the concentration of plasma inflammatory involving STAT3 and its crosstalk with NF-kB-dependent signaling.
Eur J Cell Biol 2012;91:496–505.
markers 1 d after birth, with the elevation in IL-6 slightly pre- 11. Pietrangelo A, Trautwein C. Mechanisms of disease: the role of hep-
ceding CRP and SAA (50). This could represent a normal cidin in iron homeostasis–implications for hemochromatosis and other
physiologic response to change from the intrauterine to the ex- disorders. Nat Clin Pract Gastroenterol Hepatol 2004;1:39–45.
trauterine environment and concomitant physiologic changes in 12. Agarwal N, Prchal JT. Anemia of chronic disease (anemia of in-
flammation). Acta Haematol 2009;122:103–8.
lung function (51). Whether these differences are significant as 13. Nemeth E, Ganz T. Anemia of inflammation. Hematol Oncol Clin
signals for changes in iron homeostasis still must be tested. In North Am 2014;28:671–81.
infants in an Indonesian population with widespread iron in- 14. Koenig MD, Tussing-Humphreys L, Day J, Cadwell B, Nemeth E.
sufficiency, significant correlations were found between ferritin Hepcidin and iron homeostasis during pregnancy. Nutrients 2014;6:
3062–83.
concentrations, as an iron-related AP protein, and both CRP and 15. Gozzelino R. The pathophysiology of heme in the brain. Curr Alz-
AGP concentrations, although infants with elevations in either heimer Res 2016;13:174–84.
CRP or AGP did not differ from infants in whom both of these 16. Winterbourn CC. Toxicity of iron and hydrogen peroxide: the Fenton
proteins were elevated (52). reaction. Toxicol Lett 1995;82–83:969–74.
17. Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ,
Figdor CG. Different faces of the heme-heme oxygenase system in
inflammation. Pharmacol Rev 2003;55:551–71.
CONCLUSIONS 18. Smith A, McCulloh RJ. Hemopexin and haptoglobin: allies against
Mechanisms by which inflammatory processes regulate iron heme toxicity from hemoglobin not contenders. Front Physiol 2015;6:
187.
homeostasis in iron-replete and iron-deficient pregnant women 19. Gabay C, Kushner I. Acute phase proteins and other systemic re-
and infants deserve additional study. Pregnancy per se may be too sponses to inflammation. N Engl J Med 1999;340:448–54.
broad a category, and effects at different stages, including the 20. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in
time of implantation, pregnancy maintenance, and parturition, inflammation and metabolism. Am J Clin Nutr 2006;83(Suppl):461S–
5S.
may be necessary to parse out differences due to differences 21. Huh JY, Park YJ, Ham M, Kim JB. Crosstalk between adipocytes and
intrinsic to these physiologic states. Studies in children from birth immune cells in adipose tissue inflammation and metabolic dysregu-
and after the time when prenatal iron stores are exhausted are also lation in obesity. Mol Cells 2014;37:365–71.
INFLAMMATION AND IRON HOMEOSTASIS 7S of 7S
22. Aldred AR, Schreiber G. The negative acute phase proteins. In: 38. Harrison-Findik DD, Lu S. The effect of alcohol and hydrogen per-
Mackiewicz A, Kushner I, Bauman H, editors. Acute phase proteins oxide on liver hepcidin gene expression in mice lacking antioxidant
molecular biology, biochemistry, and clinical applications. Boca Raton enzymes, glutathione peroxidase-1 or catalase. Biomolecules 2015;5:
(FL): CRC Press; 1993. p. 21–37. 793–807.
23. Gitlin JD, Colten HR. Molecular biology of the acute phase proteins. 39. Bayele HK, Balesaria S, Srai SK. Phytoestrogens modulate hepcidin
In: Pick E, Landy M, editors. Lymphokines. San Diego (CA): Aca- expression by Nrf2: implications for dietary control of iron absorption.
demic Press; 1987. p. 123–53. Free Radic Biol Med 2015;89:1192–202.
24. Kilicarslan A, Uysal A, Roach EC. Acute phase reactants. Acta Medica 40. Bayele HK, Srai SKS. Genetic variation in hepcidin expression and its
(Cordoba) 2013;2:2–7. implications for phenotypic differences in iron metabolism. Haema-
25. Schreiber G, Tsykin A, Aldred AR, Thomas T, Fung W-P, Dickson PW, tologica 2009;94:1185–8.
Cole T, Birch H, De Jong FA, Milland J. The acute phase response in 41. Legrand D. Lactoferrin, a key molecule in immune and inflammatory
the rodent. Ann N Y Acad Sci 1989;557:61–85. processes. Biochem Cell Biol 2012;90:252–68.
26. van Wijk F, Cheroutre H. Mucosal T cells in gut homeostasis and in- 42. Papanastasiou DA, Vayenas DV, Vassilopoulos A, Repanti M. Con-
flammation. Expert Rev Clin Immunol 2010;6:559–66. centration of iron and distribution of iron and transferrin after experi-
27. Sampson HA. Food allergies. In: Feldman M, Friedman LS, Brandt LJ, mental iron overload in rat tissues in vivo: study of the liver, the spleen,
editors. Sleisenger and Fordtran’s gastrointestinal and liver disease. the central nervous system and other organs. Pathol Res Pract 2000;
Philadelphia: Elsevier, Saunders; 2015. 196:47–54.
28. Harrison OJ, Powrie FM. Regulatory T cells and immune tolerance in 43. Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by
the intestine. Cold Spring Harb Perspect Biol 2013;5:a018341. heme oxygenase-1. Annu Rev Pharmacol Toxicol 2010;50:323–54.
29. Rozing J, de Geus B. Changes in the intestinal lymphoid compartment 44. Origassa CS, Câmara NO. Cytoprotective role of heme oxygenase-1
throughout life: implications for the local generation of intestinal and heme degradation derived end products in liver injury. World J
T cells. Int Rev Immunol 1995;12:13–25. Hepatol 2013;5:541–9.
30. Burroughs AK. The hepatic artery, portal venous system and portal hy- 45. Haram K, Augensen K, Elsayed S. Serum protein pattern in normal
pertension: the hepatic veins and liver in circulatory failure. In: Dooley JS, pregnancy with reference to acute-phase reactants. Br J Obstet Gy-
Lok ASF, Burroughs AK, Heathcote EJ, editors. Sherlock’s diseases of naecol 1983;90:139–45.
the liver and biliary system. London: Wiley Blackwell; 2011. p. 152–209. 46. Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and preg-
31. Trautwein C, Böker K, Manns MP. Hepatocyte and immune system: nancy: the role of the immune system at the implantation site. Ann N Y
acute phase reaction as a contribution to early defence mechanisms. Acad Sci 2011;1221:80–7.
Gut 1994;35:1163–6. 47. Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel LA,
32. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory Nien JK. Inflammation in preterm and term labour and delivery. Semin
proliferative disease. Cytokine Growth Factor Rev 2002;13:357–68. Fetal Neonatal Med 2006;11:317–26.
33. Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell 48. Hedengran KK, Nelson D, Andersen MR, Stender S, Szecsi PB.
growth, differentiation and survival signals relayed through the IL-6 Hepcidin levels are low during pregnancy and increase around delivery
family of cytokine receptors. Oncogene 2000;19:2548–56. in women without iron deficiency—a prospective cohort study. J Ma-
34. Piperno A, Mariani R, Trombini P, Girelli D. Hepcidin modulation in tern Fetal Neonatal Med 2016;29:1506–8.
human diseases: from research to clinic. World J Gastroenterol 2009; 49. Levytska K, Kingdom J, Baczyk D, Drewlo S. Heme oxygenase-1 in
15:538–51. placental development and pathology. Placenta 2013;34:291–8.
35. Maisetta G, Petruzzelli R, Brancatisano FL, Esin S, Vitali R, Campa M, 50. Marchini G, Berggren V, Djilali-Merzoug R, Hansson LO. The birth
Batoni G. Antimicrobial activity of human hepcidin 20 and 25 against process initiates an acute phase reaction in the fetus–newborn infant.
clinically relevant bacterial strains: effect of copper and acidic pH. Acta Paediatr 2000;89:1082–6.
Peptides 2010;31:1995–2002. 51. Hooper SB, Te Pas AB, Kitchen MJ. Respiratory transition in the
36. Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann WG, Schulz- newborn: a three-phase process. Arch Dis Child Fetal Neonatal Ed
Knappe P, Adermann K. LEAP-1, a novel highly disulfide-bonded human 2016;101:F266–71.
peptide, exhibits antimicrobial activity. FEBS Lett 2000;480:147–50. 52. Wieringa FT, Dijkhuizen MA, Clive E, West CE, Northrop-Clewes CA,
37. Shi W, Wang H, Zheng X, Jiang X, Xu Z, Shen H, Li M. HNF-4alpha Muhilal. Estimation of the effect of the acute phase response on in-
negatively regulates hepcidin expression through BMPR1A in HepG2 dicators of micronutrient status in Indonesian infants. J Nutr 2002;132:
cells. Biol Trace Elem Res 2017;176:294–304. 3061–6.